Literature DB >> 27269021

Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians.

Yuhua Bao1, Yijun Pan2, Aryn Taylor3, Sharmini Radakrishnan4, Feijun Luo5, Harold Alan Pincus6, Bruce R Schackman7.   

Abstract

State prescription drug monitoring programs are promising tools to rein in the epidemic of prescription opioid overdose. We used data from a national survey to assess the effects of these programs on the prescribing of opioid analgesics and other pain medications in ambulatory care settings at the point of care in twenty-four states from 2001 to 2010. We found that the implementation of a prescription drug monitoring program was associated with more than a 30 percent reduction in the rate of prescribing of Schedule II opioids. This reduction was seen immediately following the launch of the program and was maintained in the second and third years afterward. Effects on overall opioid prescribing and prescribing of non-opioid analgesics were limited. Increased use of these programs and the adoption of new policies and practices governing their use may have contributed to sustained effectiveness. Future studies are needed to evaluate the policies' comparative effectiveness. Project HOPE—The People-to-People Health Foundation, Inc.

Entities:  

Keywords:  Behavioral Health; PDMP; Prescription Drug Monitoring Programs

Mesh:

Substances:

Year:  2016        PMID: 27269021      PMCID: PMC5336205          DOI: 10.1377/hlthaff.2015.1673

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  18 in total

1.  Awareness and utilization of a prescription monitoring program among physicians.

Authors:  Lance Feldman; Kristi Skeel Williams; John Coates; Michele Knox
Journal:  J Pain Palliat Care Pharmacother       Date:  2011-09-21

Review 2.  What we know, and don't know, about the impact of state policy and systems-level interventions on prescription drug overdose.

Authors:  Tamara M Haegerich; Leonard J Paulozzi; Brian J Manns; Christopher M Jones
Journal:  Drug Alcohol Depend       Date:  2014-10-14       Impact factor: 4.492

3.  Schedules of controlled substances: rescheduling of hydrocodone combination products from schedule III to schedule II. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2014-08-22

4.  Physician perspectives on a pilot prescription monitoring program.

Authors:  Kirsten Barrett; Ashby Watson
Journal:  J Pain Palliat Care Pharmacother       Date:  2005

5.  Characteristics of opioid prescriptions in 2009.

Authors:  Nora D Volkow; Thomas A McLellan; Jessica H Cotto; Meena Karithanom; Susan R B Weiss
Journal:  JAMA       Date:  2011-04-06       Impact factor: 56.272

6.  Prescription drug monitoring programs and death rates from drug overdose.

Authors:  Leonard J Paulozzi; Edwin M Kilbourne; Hema A Desai
Journal:  Pain Med       Date:  2011-02-18       Impact factor: 3.750

7.  Patterns of abuse among unintentional pharmaceutical overdose fatalities.

Authors:  Aron J Hall; Joseph E Logan; Robin L Toblin; James A Kaplan; James C Kraner; Danae Bixler; Alex E Crosby; Leonard J Paulozzi
Journal:  JAMA       Date:  2008-12-10       Impact factor: 56.272

8.  Prescription opioid usage and abuse relationships: an evaluation of state prescription drug monitoring program efficacy.

Authors:  Richard M Reisman; Pareen J Shenoy; Adam J Atherly; Christopher R Flowers
Journal:  Subst Abuse       Date:  2009-05-01

9.  Prescription drug monitoring and drug overdose mortality.

Authors:  Guohua Li; Joanne E Brady; Barbara H Lang; James Giglio; Hannah Wunsch; Charles DiMaggio
Journal:  Inj Epidemiol       Date:  2014-04-24

10.  Vital signs: variation among States in prescribing of opioid pain relievers and benzodiazepines - United States, 2012.

Authors:  Leonard J Paulozzi; Karin A Mack; Jason M Hockenberry
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-07-04       Impact factor: 17.586

View more
  94 in total

Review 1.  Pragmatic Opioid Use in Painful Diabetic Neuropathy.

Authors:  Yatan Pal Singh Balhara; Shalini Singh; Sanjay Kalra
Journal:  Eur Endocrinol       Date:  2020-02-04

2.  Implementation and enforcement of state opioid prescribing laws.

Authors:  Elizabeth M Stone; Lainie Rutkow; Mark C Bicket; Colleen L Barry; G Caleb Alexander; Emma E McGinty
Journal:  Drug Alcohol Depend       Date:  2020-06-11       Impact factor: 4.492

3.  Prescribing Associated with High-Risk Opioid Exposures Among Non-cancer Chronic Users of Opioid Analgesics: a Social Network Analysis.

Authors:  Keiki Hinami; Michael J Ray; Kruti Doshi; Maria Torres; Steven Aks; John J Shannon; William E Trick
Journal:  J Gen Intern Med       Date:  2019-08-16       Impact factor: 5.128

4.  Opioid Prescriptions in Older Medicare Beneficiaries After the 2014 Federal Rescheduling of Hydrocodone Products.

Authors:  Yong-Fang Kuo; Mukaila A Raji; Victor Liaw; Jacques Baillargeon; James S Goodwin
Journal:  J Am Geriatr Soc       Date:  2018-04-14       Impact factor: 5.562

5.  Features of prescription drug monitoring programs associated with reduced rates of prescription opioid-related poisonings.

Authors:  N J Pauly; S Slavova; C Delcher; P R Freeman; J Talbert
Journal:  Drug Alcohol Depend       Date:  2018-01-11       Impact factor: 4.492

6.  Good Samaritan harm reduction policy and drug overdose deaths.

Authors:  Danielle N Atkins; Christine Piette Durrance; Yuna Kim
Journal:  Health Serv Res       Date:  2019-02-11       Impact factor: 3.402

Review 7.  Opioid Prescribing in an Opioid Crisis: What Basic Skills Should an Oncologist Have Regarding Opioid Therapy?

Authors:  Joseph Arthur; Akhila Reddy
Journal:  Curr Treat Options Oncol       Date:  2019-04-01

8.  A Rapid Review of the Impact of Systems-Level Policies and Interventions on Population-Level Outcomes Related to the Opioid Epidemic, United States and Canada, 2014-2018.

Authors:  Bahareh Ansari; Katherine M Tote; Eli S Rosenberg; Erika G Martin
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

9.  Community pharmacies as access points for addiction treatment.

Authors:  Kevin A Look; Mercedes Kile; Katie Morgan; Andrew Roberts
Journal:  Res Social Adm Pharm       Date:  2018-06-12

10.  Prescription Drug Monitoring Program: Registration and Use by Prescribers and Pharmacists Before and After Legal Mandatory Registration, California, 2010-2017.

Authors:  Aaron B Shev; Garen J Wintemute; Magdalena Cerdá; Andrew Crawford; Susan L Stewart; Stephen G Henry
Journal:  Am J Public Health       Date:  2018-10-25       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.